Call Now (406) 245-5793

Published
Research

Below is a sampling of published research papers from All American Pharmaceutical.

Open Access Text - Efficacy and Examination of an Alkaline Buffered Commercial Creatine Supplement- Kre-Alkalyn, in Athletes
Improved Creatine Stability and pH Profile for Kre-Alkalyn
Open Access Text - The effect of an alkaline buffered creatine (Kre-Alkalyn), on cell membrane behavior, protein synthesis, and cisplatin-mediated cellular toxicity
Open Access | OMICS Publishing Group - Buffered vs. Non-Buffered Aliphatic Fatty Acids and their Anti-Proliferative Effects in Human Tumor Cell Lines
Journal of Medical Food - Liebert - Kre-Celazine as a Viable Treament for Juvenile Rheumatoid Arthritis/Juvenile Idopathic Arthritis
The Journal of the American Nutraceutical Association - A Single-Center, Double-Blind Placebo Controlled Study to Evaluate the Efficacy of Kre-Celazine, an Oral Buffered Creatine- Cetylated Fatty Acid Compound, in its Ability to Reduce Site-specific Inflammation and Pain
The Office of Orphan Product Development at FDA, has granted Kre-Celazine Orphan Drug status in the treatment of Juvenile Idiopathic Arthritis
Single-Cell Biology - Buffered vs. Non-Buffered Aliphatic Fatty Acids and their Anti-Proliferative Effects in Human Tumor Cell Lines
Rodent and Human Trials of the Testosterone Modulating Experimental Nutraceutical Taxadrol
The Effect of Increased Fiber Ingestion on Lipid Levels and Body Mass: A 4-Week Trial
A Designer Sugar, Karbolyn®, Leads to Tighter Sugar Control than Glucose in a Pre-Diabetic Cohort